View by Specialty

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

Chronic Kidney Disease News

SPONSORED CONTENT
Save
SPONSORED CONTENT
November 05, 2022
2 min read
Save

Empagliflozin lowers kidney disease progression, cardiovascular death in patients with CKD

Empagliflozin lowers kidney disease progression, cardiovascular death in patients with CKD

ORLANDO —Empagliflozin reduced kidney disease progression and cardiovascular death in patients with chronic kidney disease, according to data presented at ASN Kidney Week.

SPONSORED CONTENT
November 05, 2022
1 min read
Save

SGLT2 inhibitors may reduce risk, progression of CKD, AKI regardless of diabetes status

SGLT2 inhibitors may reduce risk, progression of CKD, AKI regardless of diabetes status

ORLANDO — SGLT2 inhibitors reduce the risk and progression of chronic kidney disease and AKI regardless of diabetes status, according to data presented at ASN Kidney Week.

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

SPONSORED CONTENT
November 03, 2022
1 min read
Save

Exclusion of race may lead to classification of living kidney donor as having CKD

Exclusion of race may lead to classification of living kidney donor as having CKD

ORLANDO —Use of the 2021 Chronic Kidney Disease Epidemiology Collaboration eGFR formula may lead to incorrect classification of Black living kidney donors as having CKD, according to data presented here.

SPONSORED CONTENT
November 03, 2022
2 min read
Save

Study shows no detrimental impact of continuing cardiac drugs with advanced CKD

Study shows no detrimental impact of continuing cardiac drugs with advanced CKD

ORLANDO — Patients with chronic kidney disease did not see a change in kidney function when clinicians continued a course of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, according to a study presented here.

SPONSORED CONTENT
November 02, 2022
2 min read
Save

Dapagliflozin seen as cost-effective for CKD in the United Kingdom, Germany, Spain

Dapagliflozin seen as cost-effective for CKD in the United Kingdom, Germany, Spain

In the United Kingdom, Germany and Spain, dapagliflozin with standard therapy is a cost-effective treatment for chronic kidney disease, according to data published in the Clinical Journal of the American Society of Nephrology.

SPONSORED CONTENT
November 01, 2022
2 min read
Save

Clopidogrel plus aspirin lowers risk for second stroke in normal renal function

Clopidogrel plus aspirin lowers risk for second stroke in normal renal function

After a minor stroke or transient ischemic attack, patients with normal vs. impaired renal function treated with ticagrelor plus aspirin had lower risk for stroke at 90 days compared with clopidogrel plus aspirin, researchers reported.

SPONSORED CONTENT
October 31, 2022
2 min read
Save

Children with solitary functioning kidney at significant risk for kidney injury

Children with solitary functioning kidney at significant risk for kidney injury

Pediatric patients with a solitary functioning kidney are at a significant risk for developing kidney injury before adulthood, according to data published in Kidney International Reports.

SPONSORED CONTENT
October 28, 2022
2 min read
Save

Among patients with non-dialysis CKD, 83% report fatigue

Among patients with non-dialysis CKD, 83% report fatigue

Symptom prevalence ranged among patients with non-dialysis chronic kidney disease, with 24% reporting chest pain and 83% reporting fatigue, according to data published in the Clinical Journal of the American Society of Nephrology.

SPONSORED CONTENT
October 27, 2022
2 min read
Save

Finerenone may lower risks for pneumonia, COVID-19 in adults with type 2 diabetes and CKD

Finerenone may lower risks for pneumonia, COVID-19 in adults with type 2 diabetes and CKD

Adults with type 2 diabetes and chronic kidney disease using the nonsteroidal mineralocorticoid receptor antagonist finerenone have lower risks for pneumonia and COVID-19, according to findings published in JAMA Network Open.

SPONSORED CONTENT
October 26, 2022
2 min read
Save

Patient education increases shared decision-making among older adults with advanced CKD

Patient education increases shared decision-making among older adults with advanced CKD

Among older adults with advanced chronic kidney disease, those who knew the range of kidney treatment options or attended an educational class about their options were more likely to engage in shared decision-making, according to a study.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails